These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16728547)

  • 1. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
    Schirpenbach C; Seiler L; Maser-Gluth C; Rüdiger F; Nickel C; Beuschlein F; Reincke M
    Eur J Endocrinol; 2006 Jun; 154(6):865-73. PubMed ID: 16728547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of urinary aldosterone for the diagnosis of primary aldosteronism.
    Ceral J; Malirova E; Ballon M; Solar M
    Horm Metab Res; 2014 Aug; 46(9):663-7. PubMed ID: 24810470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of primary aldosteronism in primary care: a cross-sectional study.
    Käyser SC; Deinum J; de Grauw WJ; Schalk BW; Bor HJ; Lenders JW; Schermer TR; Biermans MC
    Br J Gen Pract; 2018 Feb; 68(667):e114-e122. PubMed ID: 29335324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary aldosteronism: A common and curable form of hypertension.
    Young WF
    Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
    Myśliwiec J; Zukowski Ł; Grodzka A; Piłaszewicz A; Dragowski S; Górska M
    J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):367-71. PubMed ID: 22406967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions.
    Vorselaars WMCM; Valk GD; Vriens MR; Westerink J; Spiering W
    J Hypertens; 2018 Jul; 36(7):1585-1591. PubMed ID: 29528872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.
    Willenberg HS; Vonend O; Schott M; Gao X; Blondin D; Saleh A; Rump LC; Scherbaum WA
    Horm Metab Res; 2012 Jun; 44(7):527-32. PubMed ID: 22689209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.
    Abdelhamid S; Blomer R; Hommel G; Haack D; Lewicka S; Fiegel P; Krumme B
    Am J Hypertens; 2003 Jul; 16(7):522-30. PubMed ID: 12850384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for primary aldosteronism.
    Schirpenbach C; Reincke M
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):369-84. PubMed ID: 16980200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary aldosteronism.
    Gordon RD
    J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
    Reznik Y; Amar L; Tabarin A
    Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of primary hyperaldosteronism].
    Diederich S; Bidlingmaier M; Quinkler M; Reincke M
    Med Klin (Munich); 2007 Jan; 102(1):16-21. PubMed ID: 17221347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
    Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
    Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.